An increased activity of autocrine/paracrine FGF2/FGFR-mediated loops were proofed for the multiple types of malignancies, including endometrial, bladder, non-small cell lung cancer, breast, multiple myeloma, prostate, gastric and colon cancers. This evidence concerns the gene FGF2 and plasma cell myeloma.